A critical advance in cancer investigation is emerging with the use of nanobodies to restore dysfunctional p53. This vital malignant suppressor protein is frequently disabled in several forms of tumors, resulting https://bookmarkbells.com/story22024979/nanobodies-reactivate-the-p53-protein-a-promising-pathway-for-tumor-management